MAPT and Alzheimer disease: Alzheimer’s disease (AD), the most prevalent neurodegenerative cause of dementia, is defined by progressive cognitive decline alongside neuropathological hallmarks including amyloid-β (Aβ) plaques and neurofibrillary tau tangles (Lane et al., 2018; Scheltens et al., 2021).